Cargando…
Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
Previously considered rare, inherited hematologic malignancies are increasingly identified. Germline mutations in the RNA helicase DDX41 predispose to increased lifetime risks of myeloid neoplasms with disease often occurring later in life which presents challenges for germline recognition. To impro...
Autores principales: | Bannon, Sarah A., Routbort, Mark J., Montalban-Bravo, Guillermo, Mehta, Rohtesh S., Jelloul, Fatima Zahra, Takahashi, Koichi, Daver, Naval, Oran, Betul, Pemmaraju, Naveen, Borthakur, Gautam, Naqvi, Kiran, Issa, Ghayas, Sasaki, Koji, Alvarado, Yesid, Kadia, Tapan M., Konopleva, Marina, Shamanna, Rashmi Kanagal, Khoury, Joseph D., Ravandi, Farhad, Champlin, Richard, Kantarjian, Hagop M., Bhalla, Kapil, Garcia-Manero, Guillermo, Patel, Keyur P., DiNardo, Courtney D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878971/ https://www.ncbi.nlm.nih.gov/pubmed/33585199 http://dx.doi.org/10.3389/fonc.2020.582213 |
Ejemplares similares
-
Acute myeloid leukemia: current progress and future directions
por: Kantarjian, Hagop, et al.
Publicado: (2021) -
P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS
por: Bazinet, Alexandre, et al.
Publicado: (2023) -
Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure
por: Short, Nicholas J., et al.
Publicado: (2022) -
S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH VENETOCLAX IN TREATMENT-NAÏVE HIGHER-RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA
por: Bataller, Alex, et al.
Publicado: (2023) -
P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY
por: Short, Nicholas, et al.
Publicado: (2023)